Showing results (11-20 of 48) with videos related to

Sort By:
Pageof 5
Acta Neuropathologica Communications|November 16, 2016
Rubidium and potassium levels are altered in Alzheimer's disease brain and blood but not in cerebrospinal fluidBlaine R Roberts, James D Doecke, Alan Rembach, et al.
Journal of Neuroscience Research|July 21, 2004
Antisense peptide nucleic acid targeting GluR3 delays disease onset and progression in the SOD1 G93A mouse model of familial ALSAlan Rembach, Bradley J Turner, Stephen Bruce, et al.
Journal of Alzheimer'S Disease : JAD|January 24, 2015
Bayesian graphical network analyses reveal complex biological interactions specific to Alzheimer's diseaseAlan Rembach, Francesco C Stingo, Christine Peterson, et al.
International Journal of Geriatric Psychiatry|April 27, 2016
Amyloid burden and incident depressive symptoms in cognitively normal older adultsKarra D Harrington, Emma Gould, Yen Ying Lim, et al.
ACS Chemical Neuroscience|January 15, 2015
Decreased plasma iron in Alzheimer's disease is due to transferrin desaturationDominic J Hare, James D Doecke, Noel G Faux, et al.
Brain : a Journal of Neurology|April 7, 2017
Biochemically-defined pools of amyloid-β in sporadic Alzheimer's disease: correlation with amyloid PETBlaine R Roberts, Monica Lind, Aaron Z Wagen, et al.
The British Journal of Nutrition|September 19, 2015
Comparative analysis of the Cancer Council of Victoria and the online Commonwealth Scientific and Industrial Research Organisation FFQSamantha L Gardener, Stephanie R Rainey-Smith, S Lance Macaulay, et al.
Alzheimer'S & Dementia (New York, N. Y.)|December 5, 2017
A randomized, exploratory molecular imaging study targeting amyloid β with a novel 8-OH quinoline in Alzheimer's disease: The PBT2-204 IMAGINE studyVictor L Villemagne, Christopher C Rowe, Kevin J Barnham, et al.
Pageof 5